# Study of PH3 for the Prevention of Osteoporosis in Postmenopausal Women

> **NCT00693667** · PHASE2 · COMPLETED · sponsor: **PhytoHealth Corporation** · enrollment: 92 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** PH3

## Key facts

- **NCT ID:** NCT00693667
- **Lead sponsor:** PhytoHealth Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2021-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00693667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00693667, "Study of PH3 for the Prevention of Osteoporosis in Postmenopausal Women". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00693667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*